Geode Capital Management, LLC Synaptogenix, Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.23 - $0.4 $21,587 - $37,542	93,857 Added 154.84%	154,471 $41,000
Q3 2023 Nov 13, 2023	SELL	$0.28 - $1.04 $476 - $1,770	-1,702 Reduced 2.73%	60,614 $26,000
Q4 2022 Feb 13, 2023	SELL	$1.02 - $181.75 $162 - $28,898	-159 Reduced 0.25%	62,316 $72,000
Q1 2022 May 13, 2022	BUY	$6.31 - $10.09 $93,110 - $148,888	14,756 Added 30.92%	62,475 $483,000
Q4 2021 Feb 11, 2022	BUY	$8.38 - $13.72 $399,885 - $654,704	47,719 New	47,719 $406,000

30K

Ticker SNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,840,630
Market Cap $20.2M
Description
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.